Impact of viral infections on hematopoiesis: From beneficial to detrimental effects on bone marrow output

Frontiers in Immunology

Volumn 7, Issue SEP, 2016, Pages

  Pascutti, Maria Fernanda ^a   Erkelens, Martje N ^a,b   Nolte, Martijn A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antiviral; Aplastic anemia; Bone marrow; Hematopoiesis; HSC; HSPC; T cell; Viral infection

Indexed keywords

INTERLEUKIN 6; NEF PROTEIN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSACTIVATOR PROTEIN;

APLASTIC ANEMIA; APOPTOSIS; BONE MARROW; CYTOMEGALOVIRUS; HEMATOPOIESIS; HEMOPHAGOCYTIC SYNDROME; HUMAN; NONHUMAN; PANCYTOPENIA; PROTEIN EXPRESSION; REVIEW; VIRUS INFECTION; VIRUS INTERFERENCE;

EID: 84992150889     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00364     Document Type: Review

References (102)

1. Seita J, Weissman IL. Hematopoietic stem cell: self-renewal versus differentiation. Rev Syst Biol Med (2010) 2:640-53. doi:10.1002/wsbm.86.Hematopoietic
2. Busch K, Klapproth K, Barile M, Flossdorf M, Holland-Letz T, Schlenner SM, et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature (2015) 518:542-6. doi:10.1038/nature14242
3. Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature (2014) 505:327-34. doi:10.1038/nature12984
4. King KY, Goodell MA. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol (2011) 11:685-92. doi:10.1038/nri3062
5. Libregts SFWM, Nolte MA. Parallels between immune driven-hematopoiesis and T cell activation: 3 signals that relay inflammatory stress to the bone marrow. Exp Cell Res (2014) 329:239-47. doi:10.1016/j.yexcr.2014.09.016
6. Takizawa H, Boettcher S, Manz MG. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood (2012) 119:2991-3002. doi:10.1182/blood-2011-12-380113
7. Collier L, Oxford J, Kellam P. Human Virology. Oxford University Press (2016). Available from: https://books.google.nl/books?id=rN0dDAAAQBAJ
8. Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol (2014) 14:315-28. doi:10.1038/nri3665
9. Braciale TJ, Sun J, Kim TS. Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol (2012) 12:295-305. doi:10.1038/nri3166
10. Matter M, Odermatt B, Yagita H, Nuoffer J-M, Ochsenbein AF. Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med (2006) 203:2145-55. doi:10.1084/jem.20060651
11. Duan S, Thomas PG. Balancing immune protection and immune pathology by CD8+ T-cell responses to influenza infection. Front Immunol (2016) 7:25. doi:10.3389/fimmu.2016.00025
12. Bachmann MF, Kopf M. Balancing protective immunity and immunopathology. Curr Opin Immunol (2002) 14:413-9. doi:10.1016/S0952-7915(02)00363-1
13. Schuettpelz LG, Link DC. Regulation of hematopoietic stem cell activity by inflammation. Front Immunol (2013) 4:1-9. doi:10.3389/fimmu.2013.00204
14. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity (2006) 24:801-12. doi:10.1016/j.immuni.2006.04.008
15. Ueda Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med (2005) 201:1771-80. doi:10.1084/jem.20041419
16. Shi C, Jia T, Mendez-Ferrer S, Hohl TM, Serbina NV, Lipuma L, et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity (2011) 34:590-601. doi:10.1016/j.immuni.2011.02.016
17. Boettcher S, Gerosa RC, Radpour R, Bauer J, Ampenberger F, Heikenwalder M, et al. Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood (2014) 124:1393-403. doi:10.1182/blood-2014-04-570762
18. McCabe A, MacNamara KC. Macrophages: key regulators of steady-state and demand-adapted hematopoiesis. Exp Hematol (2016) 44(4):213-22. doi:10.1016/j.exphem.2016.01.003
19. de Bruin AM, Voermans C, Nolte MA. Impact of interferon-γ on hematopoiesis. Blood (2015) 124:2479-87. doi:10.1182/blood-2014-04-568451
20. Ok CY, Li L, Young KH. EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management. Exp Mol Med (2015) 47:e132. doi:10.1038/emm.2014.82
21. Klco JM, Geng B, Brunt EM, Hassan A, Nguyen TD, Kreisel FH, et al. Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility. Am J Hematol (2010) 85:106-10. doi:10.1002/ajh.21600
22. Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells (1996) 14:151-63. doi:10.1002/stem.140151
23. Mishra B, Malhotra P, Ratho RK, Singh MP, Varma S, Varma N. Human parvovirus B19 in patients with aplastic anemia. Am J Hematol (2005) 79:166-7. doi:10.1002/ajh.20347
24. Morinet F, Leruez-Ville M, Pillet S, Fichelson S. Concise review: anemia caused by viruses. Stem Cells (2011) 29:1656-60. doi:10.1002/stem.725
25. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood (2006) 108:2509-19. doi:10.1182/blood-2006-03-010777
26. Albuquerque PLMM, Silva J�nior GB, Di�genes SS, Silva HF. Dengue and aplastic anemia-a rare association. Travel Med Infect Dis (2009) 7:118-20. doi:10.1016/j.tmaid.2009.01.001
27. Brisse E, Imbrechts M, Put K, Avau A, Mitera T, Berghmans N, et al. Mouse cytomegalovirus infection in BALB/c mice resembles virus-associated secondary hemophagocytic lymphohistiocytosis and shows a pathogenesis distinct from primary hemophagocytic lymphohistiocytosis. J Immunol (2016) 196:3124-34. doi:10.4049/jimmunol.1501035
28. Pachlopnik Schmid J, Ho CH, Chr�tien F, Lefebure JM, Pivert G, Kosco-Vilbois M, et al. Neutralization of IFN-γ defeats haemophagocytosis in LCMV-infected perforin-and Rab27a-deficient mice. EMBO Mol Med (2009) 1:112-24. doi:10.1002/emmm.200900009
29. Ellis EM, P�rez-Padilla J, Gonz�lez L, Lebo E, Baker C, Sharp T, et al. Unusual cluster in time and space of dengue-associated hemophagocytic lymphohistiocytosis in Puerto Rico. Blood (2013) 122:3497.
30. Tan LH, Lum LCS, Omar SFS, Kan FK. Hemophagocytosis in dengue: comprehensive report of six cases. J Clin Virol (2012) 55:79-82. doi:10.1016/j.jcv.2012.06.005
31. Tuon FF, Gomes VS, Amato VS, Graf ME, Fonseca GHH, Lazari C, et al. Hemophagocytic syndrome associated with hepatitis A: case report and literature review. Rev Inst Med Trop Sao Paulo (2008) 50:123-7. doi:10.1590/S0036-46652008000200012
32. Doyle T, Bhagani S, Cwynarski K. Haemophagocytic syndrome and HIV. Curr Opin Infect Dis (2009) 22:1-6. doi:10.1097/QCO.0b013e32832180b0
33. Mirantes C, Passegu� E, Pietras EM. Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res (2014) 329:248-54. doi:10.1016/j.yexcr.2014.08.017
34. Ramos-Casals M, Brito-Zer�n P, L�pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet (2014) 383:1503-16. doi:10.1016/S0140-6736(13)61048-X
35. Janka GE, Lehmberg K. Hemophagocytic syndromes-an update. Blood Rev (2014) 28:135-42. doi:10.1016/j.blre.2014.03.002
36. Binder D, Fehr J, Hengartner H, Zinkernagel RM. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J Exp Med (1997) 185:517-30. doi:10.1084/jem.185.3.517
37. Sedger LM, Hou S, Osvath SR, Glaccum MB, Peschon JJ, van Rooijen N, et al. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha. J Immunol (2002) 169:6193-201. doi:10.4049/jimmunol.169.11.6193
38. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 80:170-8.
39. Sansonno D, Lotesoriere C, Cornacchiulo V, Fanelli M, Gatti P, Iodice G, et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood (1998) 92:3328-37.
40. Isomura H, Yamada M, Yoshida M, Tanaka H, Kitamura T, Oda M, et al. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol (1997) 52:406-12. doi:10.1002/(SICI)1096-9071(199708)52:4<406::AID-JMV11>3.0.CO;2-E
41. Mirandola P, Secchiero P, Pierpaoli S, Visani G, Zamai L, Vitale M, et al. Infection of CD34+ hematopoietic progenitor cells by human herpesvirus 7 (HHV-7). Blood (2000) 96:126-31.
42. Simmons P, Kaushansky K, Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci U S A (1990) 87:1386-90. doi:10.1073/pnas.87.4.1386
43. Chisaka H, Morita E, Yaegashi N, Sugamura K. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol (2003) 13:347-59. doi:10.1002/rmv.395
44. Bouzar AB, Willems L. How HTLV-1 may subvert miRNAs for persistence and transformation. Retrovirology (2008) 5:101. doi:10.1186/1742-4690-5-101
45. Ouellet DL, Plante I, Barat C, Tremblay MJ, Provost P. Emergence of a complex relationship between HIV-1 and the microRNA pathway. Methods Mol Biol (2009) 487:415-33. doi:10.1007/978-1-60327-547-7_20
46. Prost S, Le Dantec M, Aug� S, Le Grand R, Derdouch S, Auregan G, et al. Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPAR?/STAT5 signaling pathway in macaques. J Clin Invest (2008) 118:1765-75. doi:10.1172/JCI33037
47. Kolb-Maurer A, Wilhelm M, Weissinger F, Brocker E-B, Goebel W. Interaction of human hematopoietic stem cells with bacterial pathogens. Blood (2002) 100:3703-9. doi:10.1182/blood-2002-03-0898
48. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol (2002) 20:197-216. doi:10.1146/annurev.immunol.20.083001.084359
49. Y��ez A, Goodridge HS, Gozalbo D, Gil ML. TLRs control hematopoiesis during infection. Eur J Immunol (2013) 43:2526-33. doi:10.1002/eji.201343833
50. Chow J, Franz KM, Kagan JC. PRRs are watching you: localization of innate sensing and signaling regulators. Virology (2014) 47(9-480):104-9. doi:10.1016/j.virol.2015.02.051
51. Xagorari A, Chlichlia K. Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol J (2008) 2:49-59. doi:10.2174/1874285800802010049
52. Henrick BM, Yao XD, Rosenthal KL. HIV-1 structural proteins serve as PAMPs for TLR2 heterodimers significantly increasing infection and innate immune activation. Front Immunol (2015) 6:1-15. doi:10.3389/fimmu.2015.00426
53. Li M, Sun R, Xu L, Yin W, Chen Y, Zheng X, et al. Kupffer cells support hepatitis B virus-mediated CD8+ T cell exhaustion via hepatitis B core antigen-TLR2 interactions in mice. J Immunol (2015) 195:3100-9. doi:10.4049/jimmunol.1500839
54. Chen J, Ng MML, Chu JJH. Activation of TLR2 and TLR6 by dengue NS1 protein and its implications in the immunopathogenesis of dengue virus infection. PLoS Pathog (2015) 11:1-34. doi:10.1371/journal.ppat.1005053
55. Rojas JJ, Sampath P, Bonilla B, Ashley A, Hou W, Byrd D, et al. Manipulating TLR signaling increases the anti-tumor T cell response induced by viral cancer therapies. Cell Rep (2016) 15:264-73. doi:10.1016/j.celrep.2016.03.017
56. Takizawa H, Regoes RR, Boddupalli CS, Bonhoeffer S, Manz MG. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med (2011) 208:273-84. doi:10.1084/jem.20101643
57. Sioud M, Fl�isand Y, Forfang L, Lund-Johansen F. Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. J Mol Biol (2006) 364:945-54. doi:10.1016/j.jmb.2006.09.054
58. De Luca K, Frances-Duvert V, Asensio M-J, Ihsani R, Debien E, Taillardet M, et al. The TLR1/2 agonist PAM3CSK4 instructs commitment of human hematopoietic stem cells to a myeloid cell fate. Leukemia (2009) 23:2063-74. doi:10.1038/leu.2009.155
59. Herman A, Monlish D, Romine M, Bhatt S, Zippel S, Schuettpelz L. Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms. Blood Cancer J (2016) 6:e437. doi:10.1038/bcj.2016.45
60. Meg�as J, Y��ez A, Moriano S, O'Connor J-E, Gozalbo D, Gil M-L. Direct toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages. Stem Cells (2012) 30:1486-95. doi:10.1002/stem.1110
61. Welner RS, Pelayo R, Nagai Y, Garrett KP, Wuest TR, Carr DJ, et al. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood (2008) 112:3753-61. doi:10.1182/blood-2008-04-151506
62. Dorantes-Acosta E, Vadillo E, Contreras-Quiroz A, Balandr�n JC, Arriaga-Pizano L, Purizaca J, et al. TLR stimulation of bone marrow lymphoid precursors from childhood acute leukemia modifies their differentiation potentials. Biomed Res Int (2013) 2013:846724. doi:10.1155/2013/846724
63. Liu J, Guo YM, Hirokawa M, Iwamoto K, Ubukawa K, Michishita Y, et al. A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34+ cells. Exp Hematol (2012) 40:330-41. doi:10.1016/j.exphem.2011.12.002
64. Hwang S-Y, Hur K-Y, Kim J-R, Cho K-H, Kim S-H, Yoo J-Y. Biphasic RLR-IFN-β response controls the balance between antiviral immunity and cell damage. J Immunol (2013) 190:1192-200. doi:10.4049/jimmunol.1202326
65. Chattopadhyay S, Kuzmanovic T, Zhang Y, Wetzel JL, Sen GC. Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral pathogenesis. Immunity (2016) 44:1-11. doi:10.1016/j.immuni.2016.04.009
66. Zawatzky R, De Maeyer E, De Maeyer-Guignard J. Identification of individual interferon-producing cells by in situ hybridization. Proc Natl Acad Sci U S A (1985) 82:1136-40. doi:10.1073/pnas.82.4.1136
67. Zhao M, Zhang J, Phatnani H, Scheu S, Maniatis T. Stochastic expression of the interferon-β gene. PLoS Biol (2012) 10:1-16. doi:10.1371/journal.pbio.1001249
68. Klimmeck D, Hansson J, Raffel S, Vakhrushev SY, Trumpp A, Krijgsveld J. Proteomic cornerstones of hematopoietic stem cell differentiation: distinct signatures of multipotent progenitors and myeloid committed cells. Mol Cell Proteomics (2012) 11:286-302. doi:10.1074/mcp.M111.016790
69. Kajaste-Rudnitski A, Naldini L. Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells. Hum Gene Ther (2015) 26:201-9. doi:10.1089/hum.2015.036
70. Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev (2001) 65:131-5. doi:10.1128/MMBR.65.1.131
71. Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol (2010) 10:514-26. doi:10.1038/nri2802
72. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature (2009) 458:904-8. doi:10.1038/nature07815
73. Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med (2009) 15:696-700. doi:10.1038/nm.1973
74. Passegu� E, Ernst P. IFN-a wakes up sleeping hematopoietic stem cells. Nat Med (2009) 15:612-3. doi:10.1038/nm0609-612
75. Pietras EM, Lakshminarasimhan R, Techner J-M, Fong S, Flach J, Binnewies M, et al. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med (2014) 211:245-62. doi:10.1084/jem.20131043
76. Hartner JC, Walkley CR, Lu J, Orkin SH. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol (2009) 10:109-15. doi:10.1038/ni.1680
77. King KY, Baldridge MT, Weksberg DC, Chambers SM, Lukov GL, Wu S, et al. Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling. Blood (2011) 118:1525-33. doi:10.1182/blood-2011-01-328682
78. Walter D, Lier A, Geiselhart A, Thalheimer FB, Huntscha S, Sobotta MC, et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature (2015) 520:549-52. doi:10.1038/nature14131
79. Haas S, Hansson J, Klimmeck D, Loeffler D, Velten L, Uckelmann H, et al. Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell (2015) 17:422-34. doi:10.1016/j.stem.2015.07.007
80. Di Scala M, Gil-Farina I, Vanrell L, Sanchez-Bayona R, Alignani D, Olague C, et al. Chronic exposure to IFNalpha drives medullar lymphopoiesis towards T-cell differentiation in mice. Haematologica (2015) 100:1014-22. doi:10.3324/haematol.2014.115410
81. de Bruin AM, Demirel O, Hooibrink B, Brandts CH, Nolte MA. Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood (2013) 121:3578-85. doi:10.1182/blood-2012-05-432906
82. Matatall KA, Shen C-C, Challen GA, King KY. Type II interferon promotes differentiation of myeloid-biased hematopoietic stem cells. Stem Cells (2014) 32:3023-30. doi:10.1002/stem.1799
83. De Bruin AM, Libregts SF, Valkhof M, Boon L, Touw IP, Nolte MA. IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood (2012) 119:1543-54. doi:10.1182/blood-2011-07-367706
84. De Bruin AM, Buitenhuis M, Van Der Sluijs KF, Van Gisbergen KPJM, Boon L, Nolte MA. Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-γ. Blood (2010) 116:2559-69. doi:10.1182/blood-2009-12-261339
85. Young HA, Klinman DM, Reynolds DA, Grzegorzewski KJ, Nii A, Ward JM, et al. Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies. Blood (1997) 89:583-95. doi:10.1038/305239a0
86. Arens R, Tesselaar K, Baars PA, Van Schijndel GMW, Hendriks J, Pals ST, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFN-γ-mediated B cell depletion. Immunity (2001) 15:801-12. doi:10.1016/S1074-7613(01)00236-9
87. Libregts SF, Guti�rrez L, De Bruin AM, Wensveen FM, Papadopoulos P, Van Ijcken W, et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood (2011) 118:2578-88. doi:10.1182/blood-2010-10-315218
88. Wang CQ, Udupa KB, Lipschitz DA. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol (1995) 162:134-8. doi:10.1002/jcp.1041620116
89. van Gisbergen KPJM, Klarenbeek PL, Kragten NAM, Unger PP, Nieuwenhuis MBB, Wensveen FM, et al. The costimulatory molecule CD27 maintains clonally diverse CD8+ T cell responses of low antigen affinity to protect against viral variants. Immunity (2011) 35:97-108. doi:10.1016/j.immuni.2011.04.020
90. Welten SPM, Redeker A, Franken KL, Benedict CA, Yagita H, Wensveen FM, et al. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection. J Virol (2013) 87:6851-65. doi:10.1128/JVI.03305-12
91. Nolte MA, Arens R, van Os R, van Oosterwijk M, Hooibrink B, van Lier RAW, et al. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat Immunol (2005) 6:412-8. doi:10.1038/ni1174
92. Joseph C, Quach JM, Walkley CR, Lane SW, Lo Celso C, Purton LE. Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies. Cell Stem Cell (2013) 13:520-33. doi:10.1016/j.stem.2013.10.010
93. Birbrair A, Frenette PS. Niche heterogeneity in the bone marrow. Ann N Y Acad Sci (2016) 1370:82-96. doi:10.1111/nyas.13016
94. Sch�rch CM, Riether C, Ochsenbein AF. Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell (2014) 14:460-72. doi:10.1016/j.stem.2014.01.002
95. Beaupere C, Garcia M, Larghero J, F�ve B, Capeau J, Lagathu C. The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation. Aging Cell (2015) 14:534-46. doi:10.1111/acel.12308
96. Soland MA, Keyes LR, Bayne R, Moon J, Porada CD, St. Jeor S, et al. Perivascular stromal cells as a potential reservoir of human cytomegalovirus. Am J Transplant (2014) 14:820-30. doi:10.1111/ajt.12642
97. Ljungman P, Brand R, Hoek J, De La Camara R, Cordonnier C, Einsele H, et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European Group for Blood and Marrow Transplantation. Clin Infect Dis (2014) 59:473-81. doi:10.1093/cid/ciu364
98. Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, et al. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Transplantation (2009) 87:217-21. doi:10.1097/TP.0b013e3181938998
99. Althof N, Whitton JL. Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors. J Virol (2013) 87:2823-34. doi:10.1128/JVI.03004-12
100. Scumpia PO, Kelly-Scumpia KM, Delano MJ, Weinstein JS, Cuenca AG, Al-Quran S, et al. Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol (2010) 184:2247-51. doi:10.4049/jimmunol.0903652
101. Stark MA, Huo Y, Burcin TL. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity (2005) 22:285-94. doi:10.1016/j.immuni.2005.01.011
102. Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, Larocca R, et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature (2011) 474:216-9. doi:10.1038/nature10160